BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 12544867)

  • 1. Induction of tolerance to hind limb allografts in rats receiving cyclosporine A and antilymphocyte serum: effect of duration of the treatment.
    Ozer K; Oke R; Gurunluoglu R; Zielinski M; Izycki D; Prajapati R; Siemionow M
    Transplantation; 2003 Jan; 75(1):31-6. PubMed ID: 12544867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of donor-specific tolerance in rat hind-limb allografts under antilymphocyte serum and cyclosporine A protocol.
    Siemionow M; Oke R; Ozer K; Izycki D; Prajapati R
    J Hand Surg Am; 2002 Nov; 27(6):1095-103. PubMed ID: 12457363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of thymus in operational tolerance induction in limb allograft transplant model.
    Siemionow M; Izycki D; Ozer K; Ozmen S; Klimczak A
    Transplantation; 2006 Jun; 81(11):1568-76. PubMed ID: 16770246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
    J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
    Siemionow MZ; Izycki DM; Zielinski M
    Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adenovirus-mediated CTLA4 immunoglobulin based conditioning for non-myeloablative allogeneic hematopoietic cell transplantation to induce tolerance to hind limb allografts in rats].
    Pan H; Wang L; Zhang XD; Mai HX; Liu D; Liu Y; Guo SZ
    Zhonghua Wai Ke Za Zhi; 2009 Jun; 47(12):937-40. PubMed ID: 19781252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
    Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
    J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of tolerance in composite-tissue allografts.
    Siemionow M; Ortak T; Izycki D; Oke R; Cunningham B; Prajapati R; Zins JE
    Transplantation; 2002 Nov; 74(9):1211-7. PubMed ID: 12451256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapamycin, mycophenolate mofetil, methylprednisolone, and cytotoxic T-lymphocyte-associated antigen 4 immunoglobulin-based conditioning regimen to induce partial tolerance to hind limb allografts without cytoreductive conditioning.
    Pan H; Wang L; Zhang X; Zhang G; Mai H; Han Y; Guo S
    Transplant Proc; 2008 Jun; 40(5):1714-21. PubMed ID: 18589179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow.
    Hale DA; Gottschalk R; Maki T; Monaco AP
    Transplantation; 1998 Feb; 65(4):473-9. PubMed ID: 9500619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of donor-specific chimerism and tolerance in composite tissue allografts under alphabeta-T-cell receptor monoclonal antibody and cyclosporine a treatment protocols.
    Ozer K; Izycki D; Zielinski M; Siemionow M
    Microsurgery; 2004; 24(3):248-54. PubMed ID: 15160385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and maintenance of donor-specific chimerism in semi-allogenic and fully major histocompatibility complex mismatched facial allograft transplants.
    Siemionow M; Demir Y; Mukherjee A; Klimczak A
    Transplantation; 2005 Mar; 79(5):558-67. PubMed ID: 15753845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade.
    Foster RD; Pham S; Li S; Aitouche A
    Transplantation; 2003 Sep; 76(6):988-94. PubMed ID: 14508367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of antilymphocyte serum, fractionated donor bone marrow, and cyclosporine on renal allograft survival in mongrel dogs.
    Hartner WC; Markees TG; De Fazio SR; Khouri W; Maki T; Monaco AP; Gozzo JJ
    Transplantation; 1991 Nov; 52(5):784-9. PubMed ID: 1835194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide.
    Chowdhury NC; Saborio DV; Garrovillo M; Chandraker A; Magee CC; Waaga AM; Sayegh MH; Jin MX; Oluwole SF
    Transplantation; 1998 Oct; 66(8):1059-66. PubMed ID: 9808492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance induction in composite facial allograft transplantation in the rat model.
    Demir Y; Ozmen S; Klimczak A; Mukherjee AL; Siemionow M
    Plast Reconstr Surg; 2004 Dec; 114(7):1790-801. PubMed ID: 15577350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indefinite survival of skin allografts in adult thymectomized, antilymphocyte serum-treated mice given bone marrow and thymus grafts of donor origin: tolerance induction by donor bone marrow and thymus.
    Fukuzaki T; Hancock WW; Monaco AP; Maki T
    Transplantation; 1998 Apr; 65(8):1036-43. PubMed ID: 9583862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathymic injection of donor alloantigens induces donor-specific vascularized allograft tolerance without immunosuppression.
    Goss JA; Nakafusa Y; Flye MW
    Ann Surg; 1992 Oct; 216(4):409-14; discussion 414-6. PubMed ID: 1417190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extension of composite tissue allograft survival across major histocompatibility barrier under short course of anti-lymphocyte serum and cyclosporine a therapy.
    Ozer K; Gurunluoglu R; Zielinski M; Izycki D; Unsal M; Siemionow M
    J Reconstr Microsurg; 2003 May; 19(4):249-56. PubMed ID: 12858248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effect of graft perfusion with anti-T cell receptor monoclonal antibodies on survival of small bowel allografts in rat recipients treated with brequinar alone or in combination with cyclosporine and sirolimus.
    Wang M; Qu X; Stepkowski SM; Chou TC; Kahan BD
    Transplantation; 1996 Feb; 61(3):458-64. PubMed ID: 8610361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.